Molecular typing relies on molecular genetic testing and is not still routinely out there. Molecular subtypes and immunohistochemical surrogate markers in the tumors (HR, HER2, triple negative) correlate in about 70%. The differentiation of luminal A and B subtypes by HR status and proliferation markers like Ki-sixty seven may https://jimg675bxx9.life-wiki.com/user